| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 684.01B | 670.82B | 614.10B | 627.61B | 594.84B | 573.34B |
| Gross Profit | 104.04B | 100.48B | 89.16B | 81.84B | 84.32B | 75.86B |
| EBITDA | 60.12B | 56.98B | 47.02B | 44.85B | 51.75B | 45.28B |
| Net Income | 27.52B | 26.86B | 20.06B | 22.23B | 27.77B | 24.19B |
Balance Sheet | ||||||
| Total Assets | 572.61B | 642.50B | 591.64B | 577.94B | 535.62B | 491.57B |
| Cash, Cash Equivalents and Short-Term Investments | 50.39B | 40.01B | 48.25B | 51.72B | 55.61B | 43.70B |
| Total Debt | 111.17B | 133.84B | 106.43B | 115.72B | 80.62B | 57.52B |
| Total Liabilities | 252.94B | 315.72B | 272.57B | 270.00B | 228.56B | 202.69B |
| Stockholders Equity | 314.61B | 321.14B | 313.21B | 303.36B | 303.56B | 285.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.92B | 24.56B | -5.87B | 8.46B | -2.54B |
| Operating Cash Flow | 0.00 | 6.84B | 41.90B | 5.48B | 26.41B | 6.30B |
| Investing Cash Flow | 0.00 | -18.43B | -13.59B | -13.33B | -20.39B | -9.25B |
| Financing Cash Flow | 0.00 | 2.89B | -30.55B | 3.30B | 5.02B | -1.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥257.94B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
76 Outperform | ¥307.16B | 12.00 | 8.70% | 2.28% | 6.50% | 53.04% | |
74 Outperform | ¥595.64B | 13.52 | 8.34% | 2.66% | 5.14% | 12.52% | |
72 Outperform | ¥696.70B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
70 Outperform | ¥545.20B | 14.38 | ― | 2.51% | 15.47% | 64.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |